NCT02872857View on ClinicalTrials.gov

Subarachnoid Hemorrhage Recovery And Galantamine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 20, 2019

Study Completion Date

July 20, 2019

Conditions
Subarachnoid Hemorrhage
Interventions
DRUG

Placebo

Placebo will match drug capsules.

DRUG

8mg galantamine twice daily

Drug will be administered within 36 hours of hospitalization and continued for 90 days.

DRUG

12mg galantamine twice daily

Drug will be administered within 36 hours of hospitalization and continued for 90 days.

Trial Locations (2)

77030

Houston Methodist Hospital Texas Medical Center, Houston

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02872857 - Subarachnoid Hemorrhage Recovery And Galantamine | Biotech Hunter | Biotech Hunter